Regional citrate anticoagulation high-cut-off continuous veno-venous hemodialysis for COVID-19 and AKI patients in intensive care unit. | Clin Nephrol;96(6): 363-364, 2021 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Regional citrate anticoagulation high-cut-off continuous veno-venous hemodialysis for COVID-19 and AKI patients in intensive care unit.

Nalesso, Federico; Gobbi, Laura; Cattarin, Leda; Innico, Georgie; Calò, Lorenzo A.

Clin Nephrol ; 96(6): 363-364, 2021 12.

Article in English | MEDLINE | ID: covidwho-1468670

Subject(s)

Acute Kidney Injury; COVID-19; Continuous Renal Replacement Therapy; Acute Kidney Injury/diagnosis; Acute Kidney Injury/therapy; Anticoagulants/adverse effects; Citrates; Citric Acid; Humans; Intensive Care Units; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / Continuous Renal Replacement Therapy / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Clin Nephrol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / Continuous Renal Replacement Therapy / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Clin Nephrol Year: 2021 Document Type: Article